Abbott Aims For Mid-Year Products Reintroduction Following Consent Decree
This article was originally published in The Gray Sheet
Executive Summary
Abbott Laboratories hopes to reintroduce a number of its diagnostics products to the market in the second half of 2001 following a November 1999 consent decree issued by FDA.